• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: VENUS CONCEPT INC. VENUS VIVA RF MICRONEEDLING; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

VENUS CONCEPT INC. VENUS VIVA RF MICRONEEDLING; ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES Back to Search Results
Device Problem Patient-Device Incompatibility (2682)
Patient Problems Itching Sensation (1943); Rash (2033); Swelling/ Edema (4577)
Event Date 07/20/2022
Event Type  Injury  
Event Description
Venus viva rf microneedling procedure administered in my dermatologist office on (b)(6) 2022.On (b)(6) 2022 severe swelling, rash, and extreme pruritus.On (b)(6) 2022 symptoms increase and medications called in by the dermatologist involved help very little.The tissue around my eyes is swollen so much that it interferes with my vision.Fda safety report id# (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENUS VIVA RF MICRONEEDLING
Type of Device
ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES
Manufacturer (Section D)
VENUS CONCEPT INC.
MDR Report Key15113219
MDR Text Key296784605
Report NumberMW5111135
Device Sequence Number1
Product Code GEI
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Patient
Type of Report Initial
Report Date 07/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/26/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? Yes
Patient Sequence Number1
Treatment
ARMOUR THYROID 30 MG; CULTURELLE; ROSUVASTATIN 10 MG; SPIRONOLACTONE 25 MG; THERACRAN
Patient Age67 YR
Patient SexFemale
Patient Weight109 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-